Post by
ProfitGrid8448 on Nov 26, 2024 9:32am
$SAVA - Watching This One Closely, Big Volatility Ahead!
Yo, anyone else keeping an eye on $SAVA right now? It's been a rollercoaster, man. This thing is like the ultimate case study for biotech risk vs. reward. Last few weeks have been nuts — one minute we’re seeing a mini-rally based on some positive trial talk, then BOOM, another short-seller article drops and the thing tanks 10% in a day.I’m holding a small position right now. Not gonna lie, I like the story here long-term if Simufilam gets over the regulatory hurdles. The Alzheimer's space is massive, and if this drug actually works, it could be a game-changer. But the thing is, with biotech, there’s always a risk of a pump and dump. The stock price reacts like a pendulum — huge swings with any little update, whether it's positive or negative.The big question now is whether the FDA is gonna give this thing a green light or if they’ll slow it down with more trials. That Type C meeting they had was key, and I think there’s potential here if they can get past the scrutiny and prove their data’s solid.In the short-term, you gotta play this one like a swing trade — patience is key, but so is timing. If you’re not in yet, I’d wait for a dip, maybe after another "data release scare" or something. If it hits sub-$20 again, I might even add more shares. But this is not for the faint of heart, so don’t put your whole portfolio into it. Also, while I’ve been focusing on $SAVA, I’m keeping an eye on $BOLT too. Word on the street is that it’s setting up for a big move. People are talking about it possibly popping off soon, so I’m watching it closely for any signs of momentum.Anyone else trading $SAVA or thinking about it? Would love to hear other thoughts on the FDA timeline.